New Study Finds Unprecedented 340B Growth Likely to Continue Over Next Five Years, 340B Drug Pricing Program Projected to Exceed $23B in Total Purchases
WASHINGTON, D.C. (December 6, 2016) – A new study released today by the Alliance for Integrity and Reform of 340B (AIR 340B) projects the 340B Drug Pricing Program will continue to expand at an unprecedented rate through 2021, by which time it is expected to exceed $23 billion in total purchases at the 340B price. This rapid expansion would see 340B purchases surpass current Medicare Part B drug reimbursement purchases over the next five years.
New Report: Increasing Number of 340B Hospitals Provide Minimal Charity Care 64 Percent of 340B Hospitals Provide Less Charity Care than the National All-Hospital Average
WASHINGTON, D.C. (May 12, 2016) – The Alliance for Integrity and Reform of 340B (AIR340B) today released a new report using public data analyzed by Avalere Health that found a dramatic decline in charity care provided by 340B hospitals in 2014—the first year of the Affordable Care Act’s coverage expansion. Specifically, more than one-third (37 percent) of 340B hospitals provided charity care representing less than 1 percent of total patient costs in 2014. This is notably higher than the 24 percent of hospitals with that low level of charity care in 2011.
New Report Finds 340B Hospitals Have Low Compliance with ACA Charity Care Requirements
Research Shows Charity Care Non-Compliance Rates at ~40 Percent for 340B and Non-340B Hospitals
WASHINGTON, D.C. (April 25, 2016) – The Alliance for Integrity and Reform of 340B (AIR340B) today released a new report from the Berkeley Research Group (BRG) examining hospitals’ compliance with the Affordable Care Act’s (ACA) charity care requirements. The report, which expands on a study published in the New England Journal of Medicine(NEJM) last year, found large numbers of both 340B and non-340B hospitals not complying with key ACA protections for low-income patients.
New Fact Sheet Compares, Examines Distribution of Physician Administered Drugs Among 340B and Non-340B Hospitals
Research Reveals 340B Hospitals Are Driving Growth and Distorting the Market
WASHINGTON, D.C. (February 2, 2016) – A new fact sheet released today by the Alliance for Integrity and Reform of 340B (AIR340B) uses research from the Berkeley Research Group (BRG) on Medicare Part B hospital outpatient reimbursements. The research found 340B hospitals account for the majority of Part B reimbursement compared to non-340B hospitals and 340B hospitals have been driving most of the growth in Part B reimbursement over time.
340B Hospitals Are More Likely to Acquire Physician Practices, New Study Suggests
New Report Examines Physician Practice Acquisitions in 340B Drug Pricing Program
WASHINGTON, D.C. (June 8, 2015) – A new analysis released today by Avalere Health and funded by the Alliance for Integrity and Reform of 340B (AIR 340B) found hospitals participating in the 340B Drug Pricing Program were more likely to acquire independent physician practices than non-340B hospitals. Read more >